Stocks and Investing Stocks and Investing
Mon, July 26, 2021

Robyn Karnauskas Initiated (ABBV) at Strong Buy and Held Target at $118 on, Jul 26th, 2021


Published on 2024-10-27 17:19:01 - WOPRAI, Robyn Karnauskas
  Print publication without navigation


Robyn Karnauskas of Truist Securities, Initiated "AbbVie Inc." (ABBV) at Strong Buy and Held Target at $118 on, Jul 26th, 2021.

Robyn has made no other calls on ABBV in the last 4 months.



There are 7 other peers that have a rating on ABBV. Out of the 7 peers that are also analyzing ABBV, 1 agrees with Robyn's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $113 on, Wednesday, May 19th, 2021


These are the ratings of the 6 analyists that currently disagree with Robyn


  • Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $126 on, Wednesday, May 12th, 2021
  • Tim Anderson of "Wolfe Research" Maintained at Buy with Increased Target to $127 on, Monday, May 3rd, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $128 on, Monday, May 3rd, 2021
  • Daniel Busby of "RBC Capital" Reiterated at Buy and Held Target at $135 on, Monday, May 3rd, 2021
  • Gary Nachman of "BMO Capital" Maintained at Buy with Increased Target to $129 on, Monday, May 3rd, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $144 on, Tuesday, March 30th, 2021
Contributing Sources